In addition, as demonstrated in sepsis, the expression levels and timing of different TREM-1 ligands may vary depending on the stage of sepsis and type of infection (146–148), further increasing risk of failure of ligand-dependent TREM-1 inhibitors. This evidence concerns the gene TREM1 and Sepsis.